tirzepatide and semaglutide Maintenance therapy on or Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

and global patients illustrates the significant runway that remains for obesity treatments and the companies developing them

These include signs of severe hypoglycaemia such as confusion, difficulty speaking, loss of consciousness, seizures, or inability to swallow safely

At week 208, mean weight loss in the semaglutide group analyzed as first on-treatment was 11.7% compared with 1.5% for the placebo group (Fig

They can assist in controlling other weight-related health issues such as cardiovascular disease or hypertension

Who may be considered for treatment and who may need caution Retatrutide is being studied primarily for adults with obesity or overweight linked to metabolic complications

weight loss, this can actually have patients resume ovulation and be able to get pregnant," Dr